On January 12, a delegation from the First Affiliated Hospital of Zhengzhou University (hereinafter referred to as "ZZU First Hospital"), led by Professor Zhang Yi, Director of the Center for Bio-Cell Therapy, and Professor Wang Liping, Director of the Third Ward of Oncology, visited Shenzhen Cell Valley. They were warmly welcomed by our Chairman, Professor Shi Yuanyuan; Chief Scientist, Professor Wang Jianxun; Minister of Marketing, Sun Rui; Director of Business, Wei Zheng; Executive Assistant to the Chairman, Fu Yuchen; Senior R&D Scientist, Dr. Zhu Wenxiang; and Director of the General Affairs Office, Wang Lu, who subsequently held a symposium with the guests.

Accompanied by Professor Shi Yuanyuan, Directors Zhang Yi and Wang Liping toured the Shenzhen Cell Valley Smart Showroom, where they gained a comprehensive understanding of the company's development history, core technologies, and scientific achievements. They also visited the production workshops and R&D laboratories, gaining a more intuitive insight into the operational workflows, production capabilities, and quality management systems.

During the symposium, Professor Shi Yuanyuan elaborated on Shenzhen Cell Valley's core advantages and future plans in the field of cell therapy. He highlighted that Shenzhen Cell Valley is dedicated to the R&D and upgrading of foundational cell therapy technologies and possesses extensive experience in cooperating with major hospitals to co-build cell preparation centers for clinical applications. Furthermore, with its advanced industrialized production system and rich experience in talent cultivation, Shenzhen Cell Valley can provide comprehensive support for the construction of such centers. In contrast, ZZU First Hospital brings a wealth of clinical experience and data resources, offering invaluable clinical guidance for these centers.

The expert team from ZZU First Hospital introduced their Bio-Cell Therapy Center as a comprehensive department integrating clinical practice, scientific research, outcome translation, and precision clinical testing. The center boasts a staff of over 30, including 15 PhD holders and 7 senior professionals. It operates a specialized bio-immunotherapy ward and hosts research platforms such as the Key Laboratory for Esophageal Cancer Prevention and Treatment (co-constructed by provincial and ministerial authorities) and the Henan International Joint Laboratory for Tumor Immunology and Biotherapy. The hospital has achieved significant results and accumulated extensive experience in cell therapy, including participation in the construction of the Central Plains Laboratory for Cell and Immunotherapy. Notably, ZZU First Hospital is one of only three stem cell clinical research institutions in Henan Province, the others being Henan Provincial People's Hospital and Zhengzhou First People's Hospital. Director Zhang Yi expressed his expectation for deep cooperation with Shenzhen Cell Valley to jointly promote the innovation and development of cell therapy technologies.

This collaboration will realize complementary advantages for both parties, jointly promoting the standardized and large-scale production of cell therapy products. Both sides agreed that as a crucial direction for the future of medicine, cell therapy holds broad market prospects and immense social value.

This visit deepened mutual understanding and trust, laying a solid foundation for future cooperation. Both parties stated they would fully leverage their respective advantageous resources to jointly promote the innovation and application of cell therapy technologies, boost industrial development, and benefit a wide range of patients.

About the First Affiliated Hospital of Zhengzhou University

As a leader in the medical field of Henan Province, the First Affiliated Hospital of Zhengzhou University enjoys a high reputation not only for its medical services but also for its consistent excellence in scientific research. In recent years, the hospital has made breakthrough progress in cardiovascular, neurological, and oncological fields, publishing numerous high-quality academic papers, with some research achievements reaching international leading levels. Additionally, ZZU First Hospital is one of the pilot hospitals for cell therapy trials in Henan Province. Its Central Plains Laboratory for Cell Immunotherapy has achieved remarkable success in the field, making significant contributions to advancing medical technology and clinical applications in China.